153 related articles for article (PubMed ID: 18836204)
21. In vitro evaluation of the stability of proline-specific endopeptidases under simulated gastrointestinal conditions.
Fuhrmann G; Leroux JC
J Control Release; 2010 Nov; 148(1):e37-9. PubMed ID: 21529612
[No Abstract] [Full Text] [Related]
22. Enzymatic gluten detoxification: the proof of the pudding is in the eating!
Stepniak D; Koning F
Trends Biotechnol; 2006 Oct; 24(10):433-4. PubMed ID: 16934352
[TBL] [Abstract][Full Text] [Related]
23. In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract.
Fuhrmann G; Leroux JC
Proc Natl Acad Sci U S A; 2011 May; 108(22):9032-7. PubMed ID: 21576491
[TBL] [Abstract][Full Text] [Related]
24. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.
Mitea C; Havenaar R; Drijfhout JW; Edens L; Dekking L; Koning F
Gut; 2008 Jan; 57(1):25-32. PubMed ID: 17494108
[TBL] [Abstract][Full Text] [Related]
25. Future treatment strategies for celiac disease.
Lindfors K; Lähdeaho ML; Kalliokoski S; Kurppa K; Collin P; Mäki M; Kaukinen K
Expert Opin Ther Targets; 2012 Jul; 16(7):665-75. PubMed ID: 22620264
[TBL] [Abstract][Full Text] [Related]
26. Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy.
Heinis C; Alessi P; Neri D
Biochemistry; 2004 May; 43(20):6293-303. PubMed ID: 15147213
[TBL] [Abstract][Full Text] [Related]
27. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues.
Pinier M; Fuhrmann G; Galipeau HJ; Rivard N; Murray JA; David CS; Drasarova H; Tuckova L; Leroux JC; Verdu EF
Gastroenterology; 2012 Feb; 142(2):316-25.e1-12. PubMed ID: 22079593
[TBL] [Abstract][Full Text] [Related]
28. Prolyl endopeptidase from Sphingomonas capsulata: isolation and characterization of the enzyme and nucleotide sequence of the gene.
Kabashima T; Fujii M; Meng Y; Ito K; Yoshimoto T
Arch Biochem Biophys; 1998 Oct; 358(1):141-8. PubMed ID: 9750174
[TBL] [Abstract][Full Text] [Related]
29. Genetic analysis and characterization of poly(aspartic acid) hydrolase-1 from Sphingomonas sp. KT-1.
Hiraishi T; Kajiyama M; Tabata K; Yamato I; Doi Y
Biomacromolecules; 2003; 4(1):80-6. PubMed ID: 12523851
[TBL] [Abstract][Full Text] [Related]
30. Bile acids as modulators of enzyme activity and stability.
Robic S; Linscott KB; Aseem M; Humphreys EA; McCartha SR
Protein J; 2011 Dec; 30(8):539-45. PubMed ID: 21965022
[TBL] [Abstract][Full Text] [Related]
31. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
32. Production of the prolyl endoprotease (PEP) from Aspergillus sp. FSDE 16 by solid-state fermentation (SSF) and use for producing a gluten-free beer.
Almeida TC; Santos SFM; Santos ESD
Biotechnol Appl Biochem; 2024 Apr; 71(2):460-476. PubMed ID: 38212282
[TBL] [Abstract][Full Text] [Related]
33. Future therapeutic options for celiac disease.
Sollid LM; Khosla C
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):140-7. PubMed ID: 16265155
[TBL] [Abstract][Full Text] [Related]
34. Redesign of catalytic center of an enzyme: aspartic to serine proteinase.
Tanaka T; Yada RY
Biochem Biophys Res Commun; 2004 Oct; 323(3):947-53. PubMed ID: 15381092
[TBL] [Abstract][Full Text] [Related]
35. Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
Piper JL; Gray GM; Khosla C
J Pharmacol Exp Ther; 2004 Oct; 311(1):213-9. PubMed ID: 15143130
[TBL] [Abstract][Full Text] [Related]
36. Two hands (or four) are better than one.
Dunn BM; Bungert J
Nat Biotechnol; 2003 Sep; 21(9):1019-21. PubMed ID: 12949566
[No Abstract] [Full Text] [Related]
37. Primary structure, recombinant expression and homology modelling of human brain prolyl oligopeptidase, an important therapeutic target in the treatment of neuropsychiatric diseases.
Tarragó T; Sabidó E; Kogan MJ; de Oliveira E; Giralt E
J Pept Sci; 2005 May; 11(5):283-7. PubMed ID: 15838896
[No Abstract] [Full Text] [Related]
38. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
39. Functional linkage between the active site of alpha-lytic protease and distant regions of structure: scanning alanine mutagenesis of a surface loop affects activity and substrate specificity.
Mace JE; Wilk BJ; Agard DA
J Mol Biol; 1995 Aug; 251(1):116-34. PubMed ID: 7643381
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
